Anna Wuolikainen

- Amyotrofisk lateralskleros (ALS)

- Kemometri

- Bioinformatik

Kontakt

anna.wuolikainen@umu.se

090-786 88 41

Verksam vid

Första forskningsingenjör (tjänstledig) vid Kemiska institutionen

KB.A4, Linnaeus väg 10 Umeå universitet, 901 87 Umeå

Publikationer Publikationer

Neurofilaments can differentiate ALS subgroups and ALS from common diagnostic mimics

Scientific Reports, Nature Publishing Group 2021, Vol. 11, (1)

Behzadi, Arvin; Pujol-Calderón, Fani; Tjust, Anton E.; et al.

Inflammatory profiles relate to survival in subtypes of amyotrophic lateral sclerosis

Neurology: Neuroimmunology and neuroinflammation, Wolters Kluwer 2020, Vol. 7, (3)

Olesen, Mads Nikolaj; Wuolikainen, Anna; Nilsson, Anna Christine; et al.

Long-term stability of the alcohol consumption biomarker phosphatidylethanol in erythrocytes at-80 degrees C

Clinical Mass Spectrometry, Elsevier 2019, Vol. 11 : 37-41

Lakso, Hans-Åke; Wuolikainen, Anna; Sundkvist, Anneli; et al.

Targeted Multiple Reaction Monitoring Analysis of CSF Identifies UCHL1 and GPNMB as Candidate Biomarkers for ALS

Journal of Molecular Neuroscience, Springer 2019, Vol. 69, (4) : 643-657

Zhu, Shaochun; Wuolikainen, Anna; Wu, Junfang; et al.

Sequence variations in C9orf72 downstream of the hexanucleotide repeat region and its effect on repeat-primed PCR interpretation: a large multinational screening study

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, Vol. 18, (3-4) : 256-264

Nordin, Angelica; Akimoto, Chizuru; Wuolikainen, Anna; et al.

Cytokine levels in interstitial brain fluid in progressive multiple sclerosis measured via intracerebral microdialysis

Multiple Sclerosis Journal, SAGE PUBLICATIONS LTD 2016, Vol. 22 : 511-511

Bergman, J.; Dring, Ann; Wuolikainen, Anna; et al.

A 50bp deletion in the SOD1 promoter lowers enzyme expression but is not associated with ALS in Sweden

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, Vol. 17, (5-6) : 452-457

Ingre, Caroline; Wuolikainen, Anna; Marklund, Stefan L.; et al.

NMR analysis of the CSF and plasma metabolome of rigorously matched amyotrophic lateral sclerosis, Parkinson's disease and control subjects

Metabolomics, Vol. 12, (6)

Wu, Junfang; Wuolikainen, Anna; Trupp, Miles; et al.

Multi-platform mass spectrometry analysis of the CSF and plasma metabolomes of rigorously matched amyotrophic lateral sclerosis, Parkinson's disease and control subjects

Molecular Biosystems, Vol. 12, (4) : 1287-1298

Wuolikainen, Anna; Jonsson, Pär; Ahnlund, Maria; et al.

Constrained randomization and multivariate effect projections improve information extraction and biomarker pattern discovery in metabolomics studies involving dependent samples

Metabolomics, Springer 2015, Vol. 11, (6) : 1667-1678

Jonsson, Pär; Wuolikainen, Anna; Thysell, Elin; et al.

Extensive size variability of the GGGGCC expansion in C9orf72 in both neuronal and non-neuronal tissues in 18 patients with ALS or FTD

Human Molecular Genetics, Vol. 24, (11) : 3133-3142

Nordin, Angelica; Akimoto, Chizuru; Wuolikainen, Anna; et al.

Metabolite and peptide levels in plasma and CSF differentiating healthy controls from patients with newly diagnosed Parkinson's disease

Journal of Parkinson's Disease, Taylor & Francis 2014, Vol. 4, (3) : 549-560

Trupp, Miles; Jonsson, Pär; Öhrfelt, Annika; et al.

Cholesterol, Oxysterol, Triglyceride, and Coenzyme Q Homeostasis in ALS. Evidence against the Hypothesis That Elevated 27-Hydroxycholesterol Is a Pathogenic Factor

PLOS ONE, Vol. 9, (11) : e113619-

Wuolikainen, Anna; Acimovic, Jure; Loevgren-Sandblom, Anita; et al.

Intense Inflammation and Nerve Damage in Early Multiple Sclerosis Subsides at Older Age: A Reflection by Cerebrospinal Fluid Biomarkers

PLOS ONE, Vol. 8, (5) : e63172-

Khademi, Mohsen; Dring, Ann M.; Gilthorpe, Jonathan D.; et al.

Multivariate analysis of inflammatory and neuronal injury markers in cerebrospinal fluid of multiple sclerosis: higher levels are associated with younger age

Journal of Neuroimmunology, Vol. 253, (1-2) : 100-100

Khademi, Mohsen; Dring, Ann; Gilthorpe, Jonathan; et al.

Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALS

Amyotrophic Lateral Sclerosis and other Motor Neuron Disorders, Vol. 13, (1) : 1-10

Otto, Markus; Bowser, Robert; Turner, Martin; et al.

ALS patients with mutations in the SOD1 gene have an unique metabolomic profile in the cerebrospinal fluid compared with ALS patients without mutations

Molecular Genetics and Metabolism, Elsevier 2012, Vol. 105, (3) : 472-478

Wuolikainen, Anna; Moritz, Thomas; Marklund, Stefan L; et al.

PloS one, Vol. 6, (4) : e17947-

Wuolikainen, Anna; Moritz, Thomas; Marklund, Stefan L; et al.

Optimization of procedures for collecting and storing of CSF for studying the metabolome in ALS

Amyotrophic Lateral Sclerosis, Vol. 10, (4) : 229-236

Wuolikainen, Anna; Hedenström, Mattias; Moritz, Thomas; et al.

Predictive metabolite profiling applying hierarchical multivariate curve resolution to GC-MS data: a potential tool for multi-parametric diagnosis

Journal of Proteome Research, American Chemical Society 2006, Vol. 5, (6) : 1407-1414

Jonsson, Pär; Sjövik-Johansson, Elin; Wuolikainen, Anna; et al.

Visa publikationer i DiVA